Will the U.S. Food and Drug Administration approve the Biologics License Application for ivonescimab on or before November 14, 2026?
How this resolves
Resolves YES if the U.S. Food and Drug Administration grants formal regulatory approval for the Biologics License Application (BLA) for ivonescimab on or before November 14, 2026. Resolves NO if the application receives a Complete Response Letter, review extension, or no approval decision by that date.
The crowd consensus and the AI's estimate stay hidden until you make your own call — no anchoring, no herding.
Make your call first — no peeking at the crowd or the AI.
The Presage is a daily forecasting platform: call real-world events before anyone reveals their hand, then build a verified track record of your judgment over time. See how it works.
Not investment advice · Research & educational use only · No money — points only. Terms · Privacy